NCT05780970 is a clinical trial of No intervention in Pediatric Obesity, sponsored by Virginia Commonwealth University.

Who is sponsoring NCT05780970?

NCT05780970 is sponsored by Virginia Commonwealth University.

What drugs are being tested in NCT05780970?

Interventions in NCT05780970: No intervention.

What condition does NCT05780970 study?

NCT05780970 studies Pediatric Obesity.

Is NCT05780970 still recruiting?

NCT05780970 is currently completed. Last updated 2 October 2024.

Last reviewed 2024-10-02 · How we verify

NCT05780970

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Exploring the Familial Reach of Adolescent Obesity Treatment

Completed Last updated 2 October 2024

What this trial tests

trial testing No intervention in Pediatric Obesity in 55 participants. Completed in 29 June 2024.

Timeline

18 January 2022

Primary endpoint
29 June 2024

29 June 2024

Quick facts

Lead sponsor	Virginia Commonwealth University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	55
Start date	18 January 2022
Primary completion	29 June 2024
Estimated completion	29 June 2024
Sites	1 location across United States

Drugs / interventions tested

No intervention

Conditions studied

Pediatric Obesity — all drugs for Pediatric Obesity →

Sponsor

Virginia Commonwealth University

Who can join

8 and older, any sex, with Pediatric Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

An observational study ancillary to the randomized clinical trial (RCT) TEENS+ (R01HD095910), a family-based lifestyle intervention, for adolescents with obesity, to determine: 1) if family-wide changes to the shared home environment are implemented, 2) if ripple effects to untreated family members are observed, and 3) whether these changes are predictive of adolescents' weight management success. Funding support from NIH via R21HD105906.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Study design and rationale for TEENS+REACH: Evaluating ripple effects of a family-based lifestyle intervention to untreated family members.
Brown KL, LaRose JG, Raynor HA, Gorin AA, et al · · 2024 · cited 1× · PMID 38404649 · DOI 10.1016/j.conctc.2024.101276

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other recruiting trials for Pediatric Obesity

Currently open trials in the same condition.

NCT06565455 — Growing Healthy Children and Families in Rural Arkansas · NA · recruiting
NCT07342855 — Comparing Outcomes Among Children With Obesity in a Community Healthy Lifestyle Program · NA · recruiting
NCT07095166 — Monitoring Eating Across Locations (MEAL) - Timing, Intake, and Mealtime Evaluation (TIME) · NA · recruiting
NCT07229508 — Developmental Trajectories of Reinforcer Pathology and Childhood Obesity · recruiting
NCT06572345 — Low EnerGy DiEt iN Adolescents With Obesity and Type 2 Diabetes: The LEGEND Study · NA · recruiting

Other Virginia Commonwealth University trials

Trials by the same sponsor.

NCT05936931 — Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening · NA · not yet recruiting
NCT07365839 — Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma · Phase 1 · not yet recruiting
NCT07178158 — Enhancing Addiction Treatment Through Psychoeducation · NA · not yet recruiting
NCT07531316 — Safety and Tolerability Study of VVZ-2471 in Healthy Volunteers · Phase 1 · not yet recruiting
NCT07426913 — Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05780970 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Virginia Commonwealth University
Last refreshed: 2 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05780970.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing